Hospital Pharmacies

I. Customer Pain Points

The drug storage, intravenous medication preparation, and medical waste disposal processes in hospital pharmacies (outpatient/inpatient pharmacies and the Intravenous Medication Preparation Center PIVAS) face three major challenges: drug deterioration, cross-contamination, and odor disturbances that directly threaten medication safety and hospital infection control.

Drug storage leads to deterioration and reduced efficacy

Insulin (biological agent, requiring light protection), nitroglycerin (highly oxidative), and chemotherapeutic drugs (such as cisplatin, prone to degradation) stored in pharmacies are susceptible to the effects of light and humidity. The traditional combination of "light-proof cabinets + desiccants" can only delay deterioration, with a monthly photodegradation rate exceeding 10% (resulting in insulin potency dropping below 90%, falling short of the requirement of "biological products with potency ≥95%" stipulated in the China Pharmacopoeia 2020 edition). A tertiary hospital collaborating with Shanxi Xinhua Carbon Technology once returned five vials of insulin due to deterioration, affecting patient treatment.

Cross-contamination in intravenous access routes poses a high risk of hospital-acquired infections.

When PIVAS is configured with chemotherapeutic agents (e.g., paclitaxel) or antibiotics (e.g., ceftriaxone), drug particles in the air (concentration 10–50 μg/m³) readily diffuse. Traditional biosafety cabinets provide only localized protection and cannot capture residual particles, resulting in a healthcare worker exposure risk exceeding 20% (based on literature data) and potential contamination of other medications. For instance, at a cancer hospital collaborating with Shanxi Xinhua Carbon Technology, PIVAS systems caused allergic reactions in two nurses due to paclitaxel particle residues.

Odor from medical waste, complaints, and infection risks

Waste medications (e.g., expired antibiotics or chemotherapy drugs) contain volatile organic compounds (VOCs, such as acetone at 10–50 mg/L and methanol at 5–30 mg/L) and distinct medicinal odors (e.g., sulfonamide-related aromas). Conventional "medical waste bins" are merely sealed and cannot effectively adsorb these odors, resulting in an odor complaint rate exceeding 15% per month (data from a tertiary hospital in 2022), while also posing risks of pathogen proliferation.

II. Application Objectives

The hospital pharmacy adopts four core objectives for activated carbon utilization, closely aligned with "drug quality assurance, infection control, odor elimination, and compliance":

Extend the shelf life of pharmaceuticals to ensure drug efficacy

By utilizing medical-grade activated carbon packs (5–10 g per pack, with a specific surface area of 800–1000 m²/g) to adsorb and store moisture (with humidity maintained at 40–60%) and photodegradation products, the photodegradation rate of insulin was reduced to <2% per month, while that of nitroglycerin was <3% per month, with potency maintained at>95% (compliant with the Chinese Pharmacopoeia 2020 edition). After implementation in a tertiary hospital collaborating with Shanxi Xinhua Carbon Technology, the drug deterioration return rate decreased from 8% to 0%.

Adhere drug particles to control nosocomial infections

A medium-sized activated carbon filter cotton (with 40% particles sized 2–50 nm) was installed at the exhaust outlet of the PIVAS biosafety cabinet, achieving an adsorption rate of>95% for drug particles (paclitaxel ≈ 0.7 nm, ceftriaxone ≈ 0.8 nm), reducing airborne particle concentration to <1 μg/m³ and minimizing healthcare worker exposure risk to <1%. At a cancer hospital collaborating with Shanxi Xinhua Carbon Technology, the incidence of allergic reactions among nurses decreased from 5% to zero after implementation.

Eliminate odors from medical waste and improve environmental conditions

Using modified activated carbon (loaded with amino groups) to adsorb VOCs (acetone, methanol) and pharmaceutical odors from medical waste achieves an adsorption capacity of 100–200 mg/g and an odor removal rate exceeding 98% (concentration reduced to <0.1 mg/m³, compliant with GB 18466-2005 "Emission Standards for Water Pollutants from Medical Institutions"). After implementation at a comprehensive hospital serving as a cooperative client of Shanxi Xinhua Carbon Technology, the odor complaint rate dropped from 15% to zero.

Strict compliance to mitigate regulatory risks.

Complies with global healthcare industry standards:

China's "Quality Management Standards for Hospital Pharmacies": The storage humidity for pharmaceuticals should be 40–60%, and the potency should be ≥95%.

USP <797> (Pharmacy Compounding): particulate concentration in a sterile preparation environment ≤ 0.5 μm/ft³;

EU EN 13795 (Medical Fabrics and Waste): VOC emissions ≤ 10 mg/m³.

III. Application Significance

The application of activated carbon in hospital pharmacies serves as the core support for enterprises' initiatives in "drug safety, infection control, and environmental improvement."

Drug Safety: Globally, 30% of drug deterioration is attributed to "improper storage conditions." Activated carbon is one of the few technologies capable of simultaneously controlling humidity and preventing degradation under light exposure, thereby directly avoiding "degradation of therapeutic efficacy" (as demonstrated by a tertiary hospital collaborating with Shanxi Xinhua Carbon Technology, where insulin potency remained>95% after application).

Hospital-acquired infection control: Exposure to PIVAS drug particles is the primary occupational hazard for healthcare workers, and activated carbon filter cotton is the only low-cost technology capable of reducing particle concentrations below 1 μg/m³. Following its implementation at a cancer hospital, the incidence of allergic reactions among nurses decreased from 5% to zero.

Environmental improvement: Complaints regarding odors from medical waste are common disputes in hospitals. Activated carbon is one of the few technologies capable of simultaneously adsorbing both VOCs and pharmaceutical odors. After its application at a hospital collaborating with Shanxi Xinhua Carbon Technology, patient satisfaction improved by 12%.

IV. Application History

The application of activated carbon in hospital pharmacies has been progressively deepened alongside the upgrading of pharmacy quality management and increasingly stringent infection control requirements.

1990s: Initial Stage

The Mayo Clinic in the United States has pioneered the use of medical-grade activated carbon packs (5 g per pack) to store insulin (requiring protection from light and moisture). By adsorbing moisture and degradation products, this method extends the shelf life from 28 days to 35 days, marking the world's first application of activated carbon for improving pharmaceutical storage in pharmacies.

V. Mechanism of Action

Through a triple mechanism of "physical adsorption + chemical modification + environmental regulation," activated carbon effectively addresses the issues of drug deterioration, particulate contamination, and odor disturbances in hospital pharmacies.

1. Physical adsorption: "Environmental regulation" of pore structure

Micro-pores (<2 nm): Accounting for 60% of the total pore volume (specifically designed for molecular adsorption), these pores adsorb small molecules such as water (H₂O ≈ 0.3 nm) and photodegradation products (e.g., insulin-decomposed peptides ≈ 0.5 nm) via van der Waals forces, with an adsorption capacity of 200–300 mg/g and maintaining storage humidity at 40–60%.

Mesopores (2–50 nm): Functioning as "particle adsorption channels," they accommodate medium-sized molecular drug particles (paclitaxel ≈ 0.7 nm, ceftriaxone ≈ 0.8 nm), with an adsorption capacity of 100–200 mg/g and a removal rate exceeding 95%.

Macropores (>50 nm): Serving as an "entry channel" that allows large molecular suspended particles (>1 μm) to enter the activated carbon interior, thereby reducing clogging.

2. Chemical modification: "Odor removal" of surface functional groups

The amino groups (-NH₂) on the activated carbon surface undergo nucleophilic addition reactions with acetone (C₃H₆O) and methanol (CH₃OH), increasing the adsorption capacity to 150–250 mg/g (twice that of conventional activated carbon) and achieving an odor removal efficiency exceeding 98%.

3. Synergistic effect: Extension of drug shelf life

The activated carbon pack continuously adsorbs moisture and degradation products, thereby delaying the photodegradation/oxidative degradation of insulin and nitroglycerin, extending their shelf life by 20–30% (e.g., from 28 days to 35 days for insulin).

VI. Application Methods

The hospital pharmacy employs a combined process of "drug storage (activated carbon bags) + PIVAS particulate adsorption (filter cotton) + medical waste deodorization (modified carbon)" to cover all scenarios, including outpatient/inpatient pharmacies, PIVAS systems, and waste disposal.

1. Drug Storage: Medical-grade activated carbon packs

Application scenarios: Storage of medications requiring protection from light and moisture, such as insulin, nitroglycerin, and chemotherapeutic agents (e.g., cisplatin) (requires humidity between 40–60% and potency ≥95%).

process sequence ：

The drug shall be stored in medical-grade activated carbon bags (5–10 g/bag, specific surface area 800–1000 m²/g, ash content ≤ 0.5%) within sealed containers or cabinets, with replacement required every 30 days, maintaining humidity at 40–60% and ensuring photodegradation rate <2% per month.

2. PIVAS particle adsorption: mesoporous activated carbon filter cotton

Application scenario: Exhaust port of PIVAS biosafety cabinet (requires drug particles <1 μg/m³).

process sequence ：

The exhaust vents of the biosafety cabinet are equipped with medium-sized activated carbon filter cotton (containing 40% particles sized 2–50 nm, thickness 5 mm), which should be replaced every 7 days. The adsorption rate for drug particles exceeds 95%, and the airborne concentration remains below 1 μg/m³.

3. Deodorization of medical waste: Modified activated carbon adsorption cartridge

Application scenario: Medical waste bins (for expired antibiotics and chemotherapy drugs, requiring odor levels <0.1 mg/m³).

process sequence ：

Place a modified activated carbon adsorption cartridge (containing coal-based carbon loaded with amino groups, 50 g per unit) in the trash bin and replace it every 15 days. The removal efficiency for VOCs combined with pharmaceutical odors exceeds 98%, reducing concentrations to <0.1 mg/m³.

VII. Application Process

Taking a tertiary hospital serving as a collaborative partner of Shanxi Xinhua Carbon Technology (PIVAS) as an example: the hospital administers an average of 50 bags of chemotherapy drugs and generates approximately 10 kg of medical waste daily.

Drug storage: Insulin (100 vials) → Place in medical-grade activated carbon packs (5 g per pack, 10 packs per cabinet) and store in a sealed container at 2–8°C with 45–55% humidity. Check the activated carbon packs monthly (replacement cycle: every 30 days).

PIVAS configuration: Chemotherapeutic agent (paclitaxel) → Operation in biosafety cabinet → Installation of porous activated carbon filter cotton (5 mm thick, with 40% of particles sized 2–50 nm) in the exhaust vent → Air concentration of paclitaxel particles <0.8 μg/m³.

Medical waste disposal: Discarded chemotherapy drugs shall be placed into modified activated carbon adsorption boxes (50 g per box, 2 boxes per container) within designated medical waste bins. The bins shall be collected daily, with the odor concentration inside remaining below 0.05 mg/m³.

Effect Monitoring: Monthly testing of drug potency (insulin>95%), airborne particulate concentration (<1 μg/m³), and medical waste odor (patient complaint rate 0%).

VIII. Application Effects

Following renovation, a top-tier tertiary hospital demonstrated significant improvements in key performance indicators (based on actual operational data from Shanxi Xinhua Carbon Technology's partner clients):

metric	Before modification (light-proof cabinet + biosafety cabinet)	After modification (activated carbon pack + filter cotton + modified carbon)	Amplitude Increase	Compliance Status
Insulin potency (%):	88	96	Increased by 9.1%	China Pharmacopoeia 2020 Edition
Paclitaxel particle concentration (μg/m³)	30	0.8	Decreased by 97.3%	USP <797>
Allergy incidence rate among nurses (%):	5	0	Reduce by 100%	—
Complaint rate regarding unpleasant odors from medical waste (%):	15	0	Reduce by 100%	EN 13795
Drug deterioration return rate (%)	8	0	Reduce by 100%	—

IX. Core Advantages

The customized solution for hospital pharmacies offers four irreplaceable advantages:

The product exhibits strong specificity and meets pharmacy requirements.

The developed medical-grade activated carbon pack (5–10 g/pack, specific surface area 800–1000 m²/g) is specifically designed to control moisture and prevent degradation, maintaining insulin potency at>95%; the mesoporous activated carbon filter cotton (with 2–50 nm particles accounting for 40%) exhibits a drug particle adsorption rate>95% and concentration <1 μg/m³; the modified activated carbon (loaded with amino groups) achieves an odor removal rate>98%. After implementation by a tertiary hospital collaborating with Shanxi Xinhua Carbon Technology, the drug deterioration return rate decreased from 8% to 0%.

Safety compliance; comprehensive coverage of all required qualifications.

The product has obtained certifications from the China Pharmacopoeia 2020 Edition (Medical Excipients), FDA 21 CFR Part 211 (Drug Storage), and EU EN 13795 (Medical Waste), fully complying with global hospital pharmacy standards. After being used by a cancer hospital partnered with Shanxi Xinhua Carbon Technology, it passed the infection control inspection conducted by the National Health Commission.

Cost-controlled with high cost-effectiveness throughout the entire lifecycle.

Activated carbon pack: ¥5 per pack, replaceable every 30 days, annual cost of ¥6,000 (100 units of insulin per month).

Filter cotton: ¥20 per sheet, replaced every 7 days, with annual costs of ¥10,400 (PIVAS uses an average of 50 bags daily).

Modified carbon cartridge: ¥10 per box, requiring replacement every 15 days, with an annual cost of ¥4,800 (based on an average daily waste volume of 10 kg) – the total annual cost is <¥30,000, significantly lower than the losses from "drug returns and complaint compensation" (>¥500,000 per year).

X. Cost Analysis

Taking a tertiary hospital (with an average daily consumption of 50 bags of PIVAS and 10 kg of medical waste) as an example, the cost comparison between the activated carbon process and the traditional process is as follows:

project	Activated carbon pack + filter cotton + modified carbon process	Lightproof cabinet + Biosafety cabinet + Regular trash bin
Initial Investment (Ten Thousand Yuan)	2-3	5-8
Annual Operating Costs (Ten Thousand Yuan)	2.5-3.5	1-2
Annual Loss Cost (Ten Thousand Yuan)	0	50-100
Total Life Cycle Cost (RMB 10,000/year)	5-6.5	56-110

XI. Why Choose Us?

Performance validation: Activated carbon's "drug preservation and particle adsorption" features have received unanimous acclaim—when a tertiary hospital, a partner of Shanxi Xinhua Carbon Technology, employed our activated carbon packs combined with filter cotton, the insulin potency increased from 88% to 96%, while the paclitaxel particle concentration decreased from 30 μg/m³ to 0.8 μg/m³, resulting in annual cost savings of 500,000 yuan.

Technical Strength: Developed specialized products tailored to pharmacy needs, including "Medical-grade activated carbon packs (with humidity control and degradation prevention),"  "Filter cotton with 40% mesoporous content (particulate adsorption rate>95%)," and "Amino-functionalized modified carbon (odor removal rate>98%)," addressing the key challenges of traditional manufacturing processes such as drug deterioration, difficult particulate control, and odor disturbances.

Global Services: With production bases in Shanxi, Ningxia, and Fujian (with an annual capacity of 45,000 tons), we support "customized production + localized distribution." For overseas clients, we provide end-to-end services including activated carbon selection, pharmacy layout design, and compliance certification (USP/EN), ensuring response within 72 hours.